Navigation Links
New Mammography Technology Effective in Detecting Breast Cancer
Date:12/1/2008

cer underwent PEM, an application of high-resolution breast positron emission tomography (PET) in which a small amount of radioactive material is injected into the body to measure metabolic activity and determine the presence of disease. The researchers used a PET unit specially developed for the breast and small body parts to perform the PEM exam.

Of 189 malignant lesions imaged, PEM detected 176 for an overall sensitivity rate of 93 percent. Fifteen percent were ductal carcinoma in situ (DCIS), a noninvasive cancer confined to the ducts of the breast; 85 percent were invasive cancer.

PEM successfully detected cancer in 100 percent of fatty breasts, 93 percent of dense breasts, 85 percent of extremely dense breasts, 93 percent of women both with and without a history of hormone replacement therapy, 90 percent of pre-menopausal women and 94 percent of post-menopausal women.

According to Dr. Schilling, PEM is well tolerated by patients, who sit upright during the exam and are not alone or closely confined as they would be during an MRI exam. While breast MRI exams produce more than 2,000 images to be interpreted, PEM produces just 48 images that can be correlated with a woman's mammogram.

"PEM is easier to use, easier to interpret and easier on the patients than MRI," Dr. Shilling said.

"It is also ideal for those patients whose MRI is difficult to interpret due to hormonal influences, women with implants, patients with metal in their bodies, or patients who suffer from claustrophobia. It is exciting that we now have a functional imaging approach with high sensitivity that compliments our current anatomic imaging modalities," she added.

Co-authors are Deepa Narayanan, M.S., and Judith Kalinyak, M.D., Ph.D.

AT A GLANCE

-- Positron emission mammography (PEM) is an effective tool for det
'/>"/>

SOURCE Radiological Society of North America (RSNA)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
2. Stereo Mammography Takes Breast Imaging to a New Dimension
3. BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ
4. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
5. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
6. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
7. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
8. DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
9. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
10. New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
11. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., BLOOMINGTON, Minn, Nov. 27 AC...dical image management software, data migration to...United States Patent and Trademark Office has appr...ion Format within a Computer Network." Acuo Techno...rtfolio of intellectual property. In general, the ...
(Date:11/25/2009)... , WESTON, Fla., Nov. 25 /PRNewswire-Firs... Sheets: ASFX) ("the Company") is pleased to annou... production management office in Shanghai, China. ...d, providing an essential gateway for the developm...d safety products for children and adults to be di...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-First...t Dr. Michael J. McKelvey, the Company,s President...ve Vice President and CFO, are scheduled to presen...ference at 1:30 PM EST on December 1, 2009 in New ...access the presentation by visiting the Company,s ...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Meridios Ltd Selected as a Nationwide CMS Qualified Registry to Report Healthcare Quality Measures 48726 1Meridios Ltd Selected as a Nationwide CMS Qualified Registry to Report Healthcare Quality Measures 48726 2Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 1Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 2Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 3Aviation Law Expert Offers Guidance on How Families of Air France Flight 447 May Seek Compensation from Airline 48721 1Aviation Law Expert Offers Guidance on How Families of Air France Flight 447 May Seek Compensation from Airline 48721 2
...cus Attention on a New Ab...ation Frontiers, Inc.,today announced that two stu...trial fibrillation catheter ablation system were p... a premier meeting for physicians that,treat cardi...versity Clinic at Regensburg, Germany,presented re...
...ences, Inc. (Nasdaq: PBIO ) ("PBI" and "the Compa...ase II Small Business Innovation Research,(SBIR) G...s of Health,(NIH). The Grant will help fund contin...and commercialization of novel, automated, and rep... important protein biomarkers,subcellular molecula...
Other Medicine Technology:Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times 2Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times 3Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 2Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 3Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 4
(Date:11/27/2009)...7 GSI Group Inc. (Pink S...ion technology products and semiconductor systems,...pany,s shareholders has been scheduled for Friday,...ting will be announced in due course. As previous...otice from Stephen Bershad, a holder of greater th...
(Date:11/27/2009)...PRNewswire-FirstCall/ -- The Gymboree Corporation .../COO, will present at the NASDAQ OMX 23rd Investor... in London, England, on Wednesday, December 2, 200...oadcast of The Gymboree Corporation,s presentation...com, click on "Our Company" at the bottom of the p...
(Date:11/27/2009)...Holdings has announced that it has become a nation... largest nonprofit organizations dedicated to arth... Delray Beach, FL (Vocus) Nove...CHO), a company specializing in the marketing and ...s, has announced today that is has become a nation...
(Date:11/27/2009)...alth™ announced today that Spectrum Health (... Enterprise orthopedic templating solution and its... (PRWEB) November 27, 2009 -- Voyant ... (Grand Rapids, Michigan) has licensed its TraumaC...ts TraumaCad Extend workflow solution, to allow it...
(Date:11/26/2009)...wswire/ -- With cold and flu season upon us, it,s ...to control the spread of infections and avoid illn...ep ourselves healthy, but to avoid transmitting il... CIC (certified in infection-control), nursing dir...h at Hospital for Special Surgery (HSS) in Manhatt...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...developed a gel that it says can treat hypogonadis...dism is a condition that causes reduced libido, er...y, and irritability. Like women who grow l... male libido and sexual function, as well as muscl...
...nown for its religious fervour, is emerging as a h...s as Astrology Doctors . Many claim that t... kidney-related problems and others, with their ge...tones are prescribed for patients after studying t...
...as found that diabetes is associated with decrease... developing heart disease . The study, pub...e JAMA/Archives journals, shows that men and women...ut diabetes. Globalization of the Western ...
...search team has identified a gene that, when mutat...rited blindness in babies . Scientists at ...experts from other centres around the world, disco...rs congenital amaurosis (LCA), comes at a time of ...
...iyo Mori said Monday she had confidence in herself...onal Japanese women who are often seen as timid. ... to Japan," Mori, 20, told her first news conferen...Fuji last month became the second Japanese to be c...
...cessfully eased the symptoms of Parkinson's diseas...splants . During the course of study, publ...f Sciences, the scientists isolated stem cells fro...monkeys with a severe form of chemically induced P...
Other Medicine News:Health News:Is Gemstone-therapy an Alternative to Treat Illness? 2Health News:Diabetes Reduces Life Expectancy, Increases Heart Disease Risk 2Health News:New Gene Discovery Raises Hope for Childhood Blindness Cure 2Health News:New Gene Discovery Raises Hope for Childhood Blindness Cure 3
SureStep Benzodiazepines (BZO 200)
SureStep Propoxyphene (PPX)
SureStep Tricyclic antidepressants (TCA)
THC/COC/MOP/AMPII/MAMPII/BZO200
Medicine Products: